.
NTEC financial statements
* Numbers in thousands
Year |
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|
Capitalization * |
8 531 | 14 739 | 27 704 | 60 826 | 3 918 | 4 031 | 9 514 |
EV * |
-15 107 | -1 637 | -25 620 | 21 580 | -5 374 | -10 640 | -10 640 |
Stock price $ |
87.6 | 103 | 125.5 | 156 | 9.28 | 4.08 | 9.63 |
Number of shares * |
97 | 143 | 221 | 390 | 422 | 988 | 988 |
EPS |
-73,35 | -93,38 | -131,79 | -111,67 | -112,74 | -14,30 | -14,30 |
Revenue * |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income * |
-7 143 | -13 362 | -29 093 | -43 543 | -47 599 | -14 128 | -14 128 |
Operating profit * |
-7 564 | -13 846 | -29 439 | -43 328 | -33 446 | -13 829 | -13 829 |
Total liabilities * |
1 640 | 2 017 | 5 747 | 7 965 | 9 745 | 6 363 | 6 363 |
Net debt * |
-23 639 | -16 376 | -53 324 | -39 246 | -7 949 | -13 737 | -13 737 |
Total assets * |
37 155 | 24 721 | 64 549 | 61 510 | 21 280 | 20 896 | 20 896 |
Equity * |
35 515 | 22 704 | 58 802 | 53 545 | 11 535 | 14 533 | 14 533 |
Cash and investments * |
30 659 | 18 228 | 55 149 | 40 579 | 10 062 | 14 671 | 14 671 |
Over the past 10 years, the maximum capitalization of Intec Pharma Ltd is 60 826, the minimum is 3 918. Maximum net income 0, Minimum net income -47 599. The maximum price of NTEC shares is 156, the minimum price is 4.08.
.
NTEC valuation
Year |
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|
P/E |
-1,19 | -1,10 | -0,95 | -1,40 | -0,08 | -0,29 | -0,67 |
P/B |
0,24 | 0,65 | 0,47 | 1,14 | 0,34 | 0,28 | 0,65 |
P/S |
0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
E/P |
-84% | -91% | -105% | -72% | -1 215% | -350% | -148% |
P/FCF |
-0,92 | -1,18 | -1,02 | -1,25 | -0,12 | -0,35 | -0,82 |
.
NTEC profitability
Year |
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|
ROE |
-20% | -59% | -49% | -81% | -413% | -97% | |
ROA |
-19% | -54% | -45% | -71% | -224% | -68% | |
ROIC |
-21% | -61% | -50% | -80% | -259% | -89% |